VEDOLIZUMAB PROVIDES CLINICAL BENEFIT OVER ONE YEAR IN PATIENTS WITH REFRACTORY INFLAMMATORY BOWEL DISEASE - RESULTS OF A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY

Raja Atreya  ¹     Daniel C. Baumgart  ²     Tony Bruns  ³     Axel Dignass  ⁴     Katrin Ende  ⁵     Jochen Hampe     Franz Hartmann     Christian Langbein     Jochen Maul     Markus F. Neurath     Jan C. Preiss     Renate Schmelz     Carsten Schmidt     Hermann Schulze     Britta Siegmund     Niels Teich     Ulrike von Arnim     Andreas Stallmach    
¹ University Erlangen-Nuremberg, Medical Department 1, Erlangen, Germany
² Charité Medical School - Humboldt-University of Berlin, Department of Gastroenterology and Hepatology, Berlin, Germany
³ Jena University Hospital, Internal Medicine, Jena, Germany
⁴ Agaplesion Markus Krankenhaus, Medizinische Klinik I, Frankfurt, Germany
⁵ HELIOS Hosp

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)